Clinical Trial Update: Inhaled Sevoflurane for ARDS Prevention [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is examining inhaled sevoflurane for prevention of acute respiratory distress syndrome, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Acute Respiratory Distress Syndrome | Phase 3 | Status: RECRUITING